Amphotericin B transfer to CSF following intravenous administration of liposomal amphotericin B | Zendy

Volker Strenger | Zendy; Andreas Meinitzer | Zendy; Josef Donnerer | Zendy; Nora Hofer | Zendy; Hans Jürgen Dornbusch | Zendy; U. Wanz | Zendy; Markus G. Seidel | Zendy; Daniela Sperl | Zendy; Herwig Lackner | Zendy; Wolfgang Schwinger | Zendy; Petra Sovinz | Zendy; Martin Benesch | Zendy; C. Urban | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Amphotericin B transfer to CSF following intravenous administration of liposomal amphotericin B

Author(s) -

Volker Strenger,

Andreas Meinitzer,

Josef Donnerer,

Nora Hofer,

Hans Jürgen Dornbusch,

U. Wanz,

Markus G. Seidel,

Daniela Sperl,

Herwig Lackner,

Wolfgang Schwinger,

Petra Sovinz,

Martin Benesch,

C. Urban

Publication year - 2014

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dku148

Subject(s) - amphotericin b , medicine , pharmacokinetics , intravenous infusions , cerebrospinal fluid , route of administration , intrathecal , pharmacology , antibiotics , anesthesia , chemotherapy , gastroenterology , biology , antifungal , microbiology and biotechnology , dermatology

Although amphotericin B (AmB) and its lipid formulations are used for the treatment of fungal infections of the CNS, the kinetics of AmB in the CSF after intravenous administration of liposomal amphotericin B (LAmB) are not well characterized.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research